dc.contributor.authors |
Kaleli, S; Varim, C; Nalbant, A; Yazar, H; Akdogan, M; |
|
dc.date.accessioned |
2020-02-27T07:23:11Z |
|
dc.date.available |
2020-02-27T07:23:11Z |
|
dc.date.issued |
2019 |
|
dc.identifier.citation |
Kaleli, S; Varim, C; Nalbant, A; Yazar, H; Akdogan, M; (2019). Interleukins As a Marker of Inflammation in Diabetic Foot Syndrome and Type 2 Diabetes Mellitus. BEZMIALEM SCIENCE, 7, 7-1 |
|
dc.identifier.issn |
2148-2373 |
|
dc.identifier.uri |
https://doi.org/10.14235/bas.galenos.2017.2077 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/65645 |
|
dc.description.abstract |
Conclusion: According to our results, IL-12 P70, IL-17 and IL-18 can be used as biomarkers for diabetic foot. Further studies arc needed to show the role of IL-12 P70, IL-17 and IL-18 levels as a biomarker in chronic inflammatory diseases. |
|
dc.language |
English |
|
dc.publisher |
BEZMIALEM VAKIF UNIV |
|
dc.rights |
info:eu-repo/semantics/openAccess |
|
dc.rights.uri |
http://creativecommons.org/licenses/by/4.0/ |
|
dc.subject |
General & Internal Medicine |
|
dc.title |
Interleukins As a Marker of Inflammation in Diabetic Foot Syndrome and Type 2 Diabetes Mellitus |
|
dc.type |
Article |
|
dc.identifier.volume |
7 |
|
dc.identifier.startpage |
1 |
|
dc.identifier.endpage |
7 |
|
dc.contributor.department |
Sakarya Üniversitesi/Tıp Fakültesi/Temel Tıp Bilimleri Bölümü |
|
dc.contributor.saüauthor |
Kaleli, Süleyman |
|
dc.contributor.saüauthor |
Varım, Ceyhun |
|
dc.contributor.saüauthor |
Nalbant, Ahmet |
|
dc.contributor.saüauthor |
Yazar, Hayrullah |
|
dc.contributor.saüauthor |
Akdoğan, Mehmet |
|
dc.relation.journal |
BEZMIALEM SCIENCE |
|
dc.identifier.wos |
WOS:000499481600002 |
|
dc.identifier.doi |
10.14235/bas.galenos.2017.2077 |
|
dc.contributor.author |
Kaleli, Süleyman |
|
dc.contributor.author |
Varım, Ceyhun |
|
dc.contributor.author |
Nalbant, Ahmet |
|
dc.contributor.author |
Yazar, Hayrullah |
|
dc.contributor.author |
Akdoğan, Mehmet |
|